Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: Implications for adrenomedullin and calcitonin gene-related peptide pharmacology

British Journal of Pharmacology

Volumn 171, Issue 3, 2014, Pages 772-788

  Watkins, H A ^a,b   Walker, C S ^a,b   Ly, K N ^a,b   Bailey, R J ^a,b   Barwell, J ^c   Poyner, D R ^c   Hay, D L ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

adrenomedullin; CGRP; GPCR; RAMP; receptor activity modifying protein

Indexed keywords

ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; INTERMEDIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING;

ADRENOMEDULLIN; CGRP; GPCR; RAMP; RECEPTOR ACTIVITY-MODIFYING PROTEIN;

ADRENOMEDULLIN; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CALCITONIN RECEPTOR-LIKE PROTEIN; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; HUMANS; MODELS, MOLECULAR; MUTANT PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTOR ACTIVITY-MODIFYING PROTEIN 2; RECEPTOR ACTIVITY-MODIFYING PROTEIN 3; RECEPTORS, ADRENOMEDULLIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS;

EID: 84892378394     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12508     Document Type: Article

References (49)

1. Aiyar N, Disa J, Pullen M, Nambi P, (2001). Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells. Mol Cell Biochem 224: 123-133.
2. Archbold JK, Flanagan JU, Watkins HA, Gingell JJ, Hay DL, (2011). Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development. Trends Pharmacol Sci 32: 591-600.
3. Bailey RJ, Hay DL, (2006). Pharmacology of the human CGRP1 receptor in Cos 7 cells. Peptides 27: 1367-1375.
4. Bailey RJ, Hay DL, (2007). Agonist-dependent consequences of proline to alanine substitution in the transmembrane helices of the calcitonin receptor. Br J Pharmacol 151: 678-687.
5. Barwell J, Miller PS, Donnelly D, Poyner DR, (2010). Mapping interaction sites within the N-terminus of the calcitonin gene-related peptide receptor; the role of residues 23-60 of the calcitonin receptor-like receptor. Peptides 31: 170-176.
6. Barwell J, Gingell JJ, Watkins HA, Archbold JK, Poyner DR, Hay DL, (2012). Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br J Pharmacol 166: 51-65.
7. Conner AC, Hay DL, Simms J, Howitt SG, Schindler M, Smith DM, et al. (2005). A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Mol Pharmacol 67: 20-31.
8. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G, et al. (2007). PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35: W522-W525.
9. Fiser A, Sali A, (2003). Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374: 461-491.
10. Fritz-Six KL, Dunworth WP, Li M, Caron KM, (2008). Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118: 40-50.
11. Fujisawa Y, Nagai Y, Miyatake A, Takei Y, Miura K, Shoukouji T, et al. (2004). Renal effects of a new member of adrenomedullin family, adrenomedullin2, in rats. Eur J Pharmacol 497: 75-80.
12. Gingell JJ, Qi T, Bailey RJ, Hay DL, (2010). A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor. Peptides 31: 1400-1404.
13. ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA, et al. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 1083-1093.
14. Hay DL, Christopoulos G, Christopoulos A, Sexton PM, (2006a). Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l- piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-d ibromo-4-hydroxyphenyl)methyl]-2- oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazoliny l) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors-the role of receptor activity modifying protein 1. Mol Pharmacol 70: 1984-1991.
15. Hay DL, Poyner DR, Sexton PM, (2006b). GPCR modulation by RAMPs. Pharmacol Ther 109: 173-197.
16. Hinson JP, Kapas S, Smith DM, (2000). Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21: 138-167.
17. Hoare SR, (2005). Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10: 417-427.
18. Hollenstein K, Kean J, Bortolato A, Cheng RK, Dore AS, Jazayeri A, et al. (2013). Structure of class B GPCR corticotropin-releasing factor receptor 1. Nature 499: 438-443.
19. Hong Y, Hay DL, Quirion R, Poyner DR, (2012). The pharmacology of adrenomedullin 2/intermedin. Brit J Pharmacol 166: 110-120.
20. Ichikawa-Shindo Y, Sakurai T, Kamiyoshi A, Kawate H, Iinuma N, Yoshizawa T, et al. (2008). The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity. J Clin Invest 118: 29-39.
21. Kusano S, Kukimoto-Niino M, Hino N, Ohsawa N, Okuda K, Sakamoto K, et al. (2012). Structural basis for extracellular interactions between calcitonin receptor-like receptor and receptor activity-modifying protein 2 for adrenomedullin-specific binding. Protein Sci 21: 199-210.
22. Laskowski RA, (2001). PDBsum: summaries and analyses of PDB structures. Nucleic Acids Res 29: 221-222.
23. Laskowski RA, Macarthur MW, Moss DS, Thornton JM, (1993). (PROCHECK): a program to check the stereochemical quality of protein structures. J Appl Cryst 26: 283-291.
24. Li H, Robertson AD, Jensen JH, (2005). Very fast empirical prediction and interpretation of protein pKa values. Proteins 61: 704-721.
25. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. (1998). RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393: 333-339.
26. Miller PS, Barwell J, Poyner DR, Wigglesworth MJ, Garland SL, Donnelly D, (2010). Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74. Biochem Biophys Res Commun 391: 437-442.
27. Moad HE, Pioszak AA, (2013). Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins. Protein Sci 22: 1775-1785.
28. Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA, (2010). Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. Biochem Biophys Res Commun 394: 141-145.
29. Pal K, Swaminathan K, Xu HE, Pioszak AA, (2010). Structural basis for hormone recognition by the Human CRFR2(alpha) G protein-coupled receptor. J Biol Chem 285: 40351-40361.
30. Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D, et al. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A 104: 13942-13947.
31. Parthier C, Reedtz-Runge S, Rudolph R, Stubbs MT, (2009). Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem Sci 34: 303-310.
32. Pioszak AA, Xu HE, (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A 105: 5034-5039.
33. Pioszak AA, Parker NR, Suino-Powell K, Xu HE, (2008). Molecular recognition of corticotropin-releasing factor by its G-protein-coupled receptor CRFR1. J Biol Chem 283: 32900-32912.
34. Pioszak AA, Parker NR, Gardella TJ, Xu HE, (2009). Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J Biol Chem 284: 28382-28391.
35. Poirot O, O'Toole E, Notredame C, (2003). Tcoffee@igs: a web server for computing, evaluating and combining multiple sequence alignments. Nucleic Acids Res 31: 3503-3506.
36. Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54: 233-246.
37. Qi T, Hay DL, (2010). Structure-function relationships of the N-terminus of receptor activity-modifying proteins. Br J Pharmacol 159: 1059-1068.
38. Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL, (2008). Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function. Mol Pharmacol 74: 1059-1071.
39. Qi T, Ly K, Poyner DR, Christopoulos G, Sexton PM, Hay DL, (2011). Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors. Peptides 32: 1060-1067.
40. Qi T, Dong M, Watkins HA, Wootten D, Miller LJ, Hay DL, (2013). Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function. Br J Pharmacol 168: 644-657.
41. Roh J, Chang CL, Bhalla A, Klein C, Hsu SY, (2004). Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279: 7264-7274.
42. Runge S, Thogersen H, Madsen K, Lau J, Rudolph R, (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 11340-11347.
43. Sali A, Blundell TL, (1993). Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234: 779-815.
44. Siu FY, He M, de Graaf C, Han GW, Yang D, Zhang Z, et al. (2013). Structure of the human glucagon class B G-protein-coupled receptor. Nature 499: 444-449.
45. Takei Y, Hyodo S, Katafuchi T, Minamino N, (2004a). Novel fish-derived adrenomedullin in mammals: structure and possible function. Peptides 25: 1643-1656.
46. Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H, Miyano S, (2004b). Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556: 53-58.
47. Underwood CR, Garibay P, Knudsen LB, Hastrup S, Peters GH, Rudolph R, et al. (2010). Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. J Biol Chem 285: 723-730.
48. Watkins HA, Rathbone DL, Barwell J, Hay DL, Poyner DR, (2012). Structure-activity relationships for alpha calcitonin gene-related peptide. Br J Pharmacol 170: 1308-1322.
49. Watkins HA, Au M, Bobby R, Archbold JK, Abdul-Manan N, Moore JM, et al. (2013). Identification of key residues involved in adrenomedullin binding to the AM1 receptor. Br J Pharmacol 169: 143-155.